Leading Players in Thailand Lorazepam Market | Top Companies 2026

Thailand Lorazepam Market Overview

According to 6Wresearch, the Thailand lorazepam market is undergoing steady growth, driven by an increased national focus on mental health awareness and the modernization of psychiatric care. The market is valued for its essential role in addressing acute anxiety disorders, as well as its usage as a pre-anesthetic medicine in the country's growing surgical and medical tourism industries.

Furthermore, innovations in pharmaceutical manufacturing, such as the development of sublingual formulations for rapid absorption and more precise blister packaging for dose management, continue to shape the competitive landscape.

Competitive Landscape

The competitive landscape in Thailand is a strategic mix of multinational research-based firms and a robust group of local "Branded Generic" manufacturers. Success in this market depends on clinical reputation, securing placement within the National List of Essential Medicines (NLEM), and maintaining a reliable supply chain to the country's extensive network of provincial and university hospitals.

Below is a list of leading players operating in the Thailand Lorazepam Market:

1. Pfizer Inc.

As the original developer of the brand Ativan, Pfizer remains the global benchmark for lorazepam purity and clinical research in the psychiatric field.

2. Teva Pharmaceutical Industries Ltd.

The world's largest generic drug manufacturer, providing a massive portfolio of CNS and anti-anxiety medications for global and Thai markets.

3. Aurobindo Pharma

A vertically integrated leader in semi-synthetic penicillins and CNS drugs, supplying high-efficacy generics to hospitals across Thailand.

4. Sun Pharmaceutical Industries Ltd.

India's largest pharma firm, maintaining a strong presence in the Thai neurology and psychiatry segments with affordable generic alternatives.

5. Sandoz International GmbH

A division of Novartis and a global leader in generic pharmaceuticals, providing high-standard lorazepam formulations for critical care.

6. Hikma Pharmaceuticals PLC

A multinational pharmaceutical group that focuses on accessible high-quality generics and injectable medications for hospital environments.

7. Vesco Pharmaceutical

A local GMP-certified manufacturer that plays a vital role in producing essential medicines and providing a stable supply for Thai patients.

8. Lannett Company Inc.

A specialist in the development and manufacture of generic versions of brand-name pharmaceutical products, specifically in the CNS space.

9. Glenmark Pharmaceuticals Ltd.

A research-led global pharmaceutical company with a significant focus on oncology, dermatology, and respiratory/CNS treatments.

10. Thai Otsuka Pharmaceutical Co., Ltd.

A joint venture with Japan's Otsuka, focusing on clinical nutrition and high-standard specialty pharmaceuticals for the Thai hospital market.

11. Siam Pharmaceutical Co., Ltd.

One of Thailand's most prominent domestic manufacturers, producing a wide range of CNS generics to support the national public health system.